Cargando…
PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044491/ http://dx.doi.org/10.1186/1546-0096-11-S2-O12 |
| _version_ | 1782319156722401280 |
|---|---|
| author | Aikawa, N Goldenstein-Schainberg, C Vendramini, M Campos, L Saad, C Moraes, J Duarte, A Precioso, A Timenesky, M Bonfa, E Silva, C |
| author_facet | Aikawa, N Goldenstein-Schainberg, C Vendramini, M Campos, L Saad, C Moraes, J Duarte, A Precioso, A Timenesky, M Bonfa, E Silva, C |
| author_sort | Aikawa, N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4044491 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40444912014-06-19 PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) Aikawa, N Goldenstein-Schainberg, C Vendramini, M Campos, L Saad, C Moraes, J Duarte, A Precioso, A Timenesky, M Bonfa, E Silva, C Pediatr Rheumatol Online J Oral Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044491/ http://dx.doi.org/10.1186/1546-0096-11-S2-O12 Text en Copyright © 2013 Aikawa et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Aikawa, N Goldenstein-Schainberg, C Vendramini, M Campos, L Saad, C Moraes, J Duarte, A Precioso, A Timenesky, M Bonfa, E Silva, C PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) |
| title | PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) |
| title_full | PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) |
| title_fullStr | PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) |
| title_full_unstemmed | PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) |
| title_short | PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA) |
| title_sort | pres-final-2177: safety and lack of autoantibody production following influenza h1n1 vaccination in patients with juvenile idiopathic arthritis (jia) |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044491/ http://dx.doi.org/10.1186/1546-0096-11-S2-O12 |
| work_keys_str_mv | AT aikawan presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT goldensteinschainbergc presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT vendraminim presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT camposl presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT saadc presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT moraesj presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT duartea presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT preciosoa presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT timeneskym presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT bonfae presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia AT silvac presfinal2177safetyandlackofautoantibodyproductionfollowinginfluenzah1n1vaccinationinpatientswithjuvenileidiopathicarthritisjia |